People with breasts and a mutation in BRCA1, BRCA2, ATM, CHEK2, CDH1, PALB2, PTEN, STK11, TP53, or other gene associated with greater than 25% increased lifetime risk of breast cancer.
People with Li Fraumeni syndrome (TP53), a syndrome associated with an increased risk of many different cancers.
People with breasts between ages 30 to 50 with Neurofibromatosis 1 because of increased breast cancer risk.